Location History:
- Kirkland, WA (US) (1993 - 1998)
- Mercer Island, WA (US) (1997 - 2000)
Company Filing History:
3 out of 156 
2 out of 1,035 
2 out of 26 
Years Active: 1993-2000
Title: Inventor Spotlight: Eric K. Yau
Introduction
Eric K. Yau, an innovative inventor based in Kirkland, WA, has made significant contributions to the field of chemical compounds with a total of nine patents to his name. His work primarily focuses on developing novel chelating compounds and methodologies for targeted delivery of diagnostic and therapeutic agents.
Latest Patents
Among his notable patents, two stand out for their relevance and innovation. The first is "Aromatic amine substituted bridged nitrogen and sulfur donor atom," which introduces aromatic amine substituted metal chelating compounds, chelates, and conjugates for targeted delivery. This invention identifies metals, such as radionuclides including Technetium-99m and Rhenium-186/188, that can be chelated by these compounds.
The second patent, "Production of nitro-benzyl-dota via direct peptide cyclization," outlines methods, compounds, and kits focused on pretargeted delivery of diagnostic and therapeutic agents. This invention highlights methods for radiometal labeling of biotin and discusses articles of manufacture beneficial in pretargeting methods.
Career Highlights
Eric K. Yau has built a commendable career, working with esteemed companies in the pharmaceutical and biotechnology sectors. He has been associated with Neorx Corporation, a company known for its work in cancer treatment and other innovative medical therapies. Additionally, he has contributed to significant research and development efforts at Isis Pharmaceuticals, Inc., recognized for advancing RNA-targeted therapies.
Collaborations
In his professional journey, Eric has collaborated with notable figures in the scientific community, including Marvin H. Caruthers, who is well-regarded for his work in nucleic acid chemistry, and Wolfgang K-d Brill, a name synonymous with advancements in molecular diagnostics. These collaborations have further enhanced the impact of his inventions and contributions to scientific advancement.
Conclusion
Eric K. Yau exemplifies the spirit of innovation and collaboration in the scientific field. With his substantial portfolio of patents and impactful contributions, he continues to pave the way for advancements in medical diagnostics and therapeutics. His work not only reflects his expertise but also showcases the importance of targeted compounds in modern medicine.